Latest news
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeatMarketBeat · Tue, 04 Aug 2026 06:21:39 GMTProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 92.5% in July - MarketBeatMarketBeat · Thu, 30 Jul 2026 11:44:20 GMTProQR Therapeutics (PRQR) to Announce Earnings on Thursday - MarketBeatMarketBeat · Thu, 30 Jul 2026 11:36:22 GMT